Related Experiment Video
Updated: Aug 8, 2026

Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
De Quervain's disease: Ultrasound-guided release
Francisco Javier Ferreira Villanova1, Vincent Martinel2, Olivier Marès3
1Hand & Wrist Surgery Chief, Orthopedic Surgery Department, Hospital Universitario San Rafael, Madrid, Spain; International Chair of Musculoskeletal Ultrasound, UCAM, Murcia, Spain.
Purpose:
This study aimed to evaluate the outcomes of a novel antegrade, ultrasound-guided release of the first extensor tendon compartment for treating De Quervain's disease.
Methods:
We conducted a retrospective, single-center study of 34 patients who underwent ultrasound-guided release of the first extensor compartment for clinically diagnosed De Quervain's disease between June 2022 and December 2023. Inclusion criteria included age >18 years and failure of conservative treatment (e.g., NSAIDs, physiotherapy, and steroid injection) for more than six weeks. Exclusion criteria were prior trigger thumb surgery and documented allergy to local anesthetics. Outcomes were assessed using pain intensity (visual analog scale, VAS), Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) scores, and complication rates.
Results:
The mean VAS for pain improved from 7.4 to 1.1, and the QuickDASH score improved from 55 to 9.4 at the final follow-up. We recorded three minor complications and no major complications.
Conclusion:
Ultrasound-guided surgical release of the first extensor compartment for De Quervain's disease is a minimally invasive, technologically advanced, and effective treatment option.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Increased Body Temperature
The Electromagnetic Spectrum
Standing Waves in a Cavity
Degenerative Disc Disease ll: Pathophysiology

